Clinical Trial Summit Kraków 2015. From biotechnology research to clinical trials – life science journey
Program
Konferencja w języku angielskim.|
June 4, 2015 | |
| Opening | |
| 12.00–12.20 | Life Science Park – Polish biotech valley
Pawel Blachno (JCI, President of the Board) |
| 12.20–13.00 | Lunch break |
| 13.00–14.40 | Presentation of JCI Clinical Trials Center
dr Tomasz Miszalski-Jamka (JCI Clinical Trial Center, Medical and Research Head) |
| Session I Chairmen: |
dr Tomasz Miszalski-Jamka, prof. Robert Hart, prof. Jeffrey Weitz |
| 14.40–15.10 | Micro RNA – current knowledge and possible future therapeutic options
prof. Marek Sanak (Jagiellonian University, Kraków, Poland) |
| 15.10–15.40 | The early-phase development of new drugs - the example of asthma
prof. Paul O’Byrne (McMaster University, Hamilton, Canada) |
| 15.40–16.10 | From genomics to immunology to clinical practice: how to develop an investigator-initiated study
prof. James Douketis (McMaster University,Hamilton, Canada) |
| 16.10–16.30 | Coffee Break |
| Session II Chairmen: |
dr hab. Wojciech Szczeklik, prof. James Douketis, prof. Paul O’Byrne, prof. P.J. Devereaux |
| 16.30–17.00 | Clinical observations while caring for patients that led to clinical studies
prof. P.J. Devereaux (McMaster University, Hamilton, Canada) |
| 17.00–17.30 | Progress in stroke prevention: the story of atrial fibrillation and stroke
prof. Robert Hart (McMaster University, Hamilton, Canada) |
| 17.30–18.00 | New insights into the molecular mechanisms of coagulation: Lessons from clinical trials with the new anticoagulants
prof. Jeffrey Weitz (McMaster University, Hamilton, Canada) |